Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Patlakas

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Respiratory Research|December 9, 2004
Application of microarray technology in pulmonary diseasesArgyris Tzouvelekis, George Patlakas, Demosthenes Bouros
Anticancer Research|May 4, 2005
Triplet chemotherapy with docetaxel, gemcitabine and liposomal doxorubicin, supported with subcutaneous amifostine and hemopoietic growth factors, in advanced non-small cell lung cancerGeorge Patlakas, Demosthenes Bouros, Sofia Tsantekidou-Pozova, et al.
Anticancer Research|November 2, 2007
Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinomaMichael I Koukourakis, George Patlakas, Marios E Froudarakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Amifostine before chemotherapy: improved tolerance profile of the subcutaneous over the intravenous routeMichael I Koukourakis, Costantinos Simopoulos, George Minopoulos, et al.
BMC Pulmonary Medicine|August 19, 2004
The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress SyndromeDemosthenes Bouros, Michael G Alexandrakis, Katerina M Antoniou, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Respiratory Research|December 9, 2004
Application of microarray technology in pulmonary diseasesArgyris Tzouvelekis, George Patlakas, Demosthenes Bouros
Anticancer Research|May 4, 2005
Triplet chemotherapy with docetaxel, gemcitabine and liposomal doxorubicin, supported with subcutaneous amifostine and hemopoietic growth factors, in advanced non-small cell lung cancerGeorge Patlakas, Demosthenes Bouros, Sofia Tsantekidou-Pozova, et al.
Anticancer Research|November 2, 2007
Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinomaMichael I Koukourakis, George Patlakas, Marios E Froudarakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Amifostine before chemotherapy: improved tolerance profile of the subcutaneous over the intravenous routeMichael I Koukourakis, Costantinos Simopoulos, George Minopoulos, et al.
BMC Pulmonary Medicine|August 19, 2004
The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress SyndromeDemosthenes Bouros, Michael G Alexandrakis, Katerina M Antoniou, et al.
Pageof 1